• Monday, Oct 25, 2021
  • Last Update : 10:34 am

Eskayef claims to produce Remdesivir but yet to submit samples to DGDA

  • Published at 08:10 pm May 8th, 2020
Remdesivir-eskayef
Remdesivir is the first drug shown to be effective against the novel coronavirus in human trials

Eskayef is among the six companies in Bangladesh to be cleared to produce the drug used to treat Covid-19  

Eskayef Pharmaceuticals has claimed to complete all steps to manufacture Remdesivir. However, the drug administration says the company is yet to submit its sample. 

The Directorate General of Drug Administration (DGDA) says the drug, used to treat coronavirus, can hit the market once they clear it after tests.

“The company will do some tests and we will do some analysis once they submit the samples,” said Ruhul Amin, a director with the DGDA.

According to him, the chemical analysis of the samples will not take much time, but it will take 14 days if a sterility test is needed. 

Eskayef is among the six drugmakers in Bangladesh, who received the DGDA's approval to produce Remdesivir. 

The others are, Beacon Pharmaceuticals, Beximco Pharmaceuticals, Incepta Pharmaceuticals, Health Care Pharmaceuticals and Square Pharmaceuticals.

“We are glad to announce that we have successfully completed all the steps to manufacture Remdesivir, so far the globally recognized only effective drug against coronavirus,” Eskayef Managing Director and CEO Simeen Hossain told the Dhaka Tribune.

Remdesivir, a drug developed by Gilead Sciences in the US, has grabbed attention as one of the most promising treatments for Covid-19, the respiratory disease caused by the novel coronavirus that has killed more than 250,000 people.

Eskayef is set to submit its sample to the DGDA on Sunday, said its Director (marketing and sales) Mohammad Mujahidul Islam.

Remdesivir will hit the market once the tests by DGDA is complete, he added.

“However, the drug will only be available at some hospitals and institutions, not in pharmacies,” said Islam.

108
Facebook 88
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail